Cleared Traditional

K132430 - STERLING OVER-THE-WIRE (OTW) PTA BALLOON DILATATION CATHETER

K132430 is an FDA 510(k) clearance for STERLING OVER-THE-WIRE (OTW) PTA BALLOO..., manufactured by Boston Scientific Corp. The device is a Class 2 Cardiovascular device with product code LIT cleared through the Traditional 510(k) pathway after a 73-day FDA review.

K132430 · Boston Scientific Corp · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2013
Decision
73d
Days
Class 2
Risk

K132430 is an FDA 510(k) clearance for the STERLING OVER-THE-WIRE (OTW) PTA BALLOON DILATATION CATHETER. Classified as Catheter, Angioplasty, Peripheral, Transluminal (product code LIT), Class II - Special Controls.

Submitted by Boston Scientific Corp (Maple Grove, US). The FDA issued a Cleared decision on October 17, 2013 after a review of 73 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Boston Scientific Corp devices

FDA 510(k) Submission Details - K132430

510(k) Number K132430 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 05, 2013
Decision Date October 17, 2013
Days to Decision 73 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
52d faster than avg
Panel avg: 125d · This submission: 73d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LIT Device Classification - Class 2, Special Controls

Product Code LIT Catheter, Angioplasty, Peripheral, Transluminal
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - LIT Catheter, Angioplasty, Peripheral, Transluminal

All 285
Devices cleared under the same product code (LIT) and FDA review panel - the closest regulatory comparables to K132430.
STERLING OVER-THE WIRE PTA BALLOON DILATATION CATHETER
K141112 · Boston Scientific · Jul 2014
GLADIATOR ELITE PTA BALLOON DILATATION CATHETER
K132810 · Boston Scientific Corp · Feb 2014
ADVANCE 34LP LOW PROFILE PTA BALLOON DILATATION CATHETER
K132020 · Cook, Inc. · Oct 2013
NANOCROSS ELITE .14 OVER-THE-WIRE PTA, BALLOON DILATION CATHETER
K132777 · Ev3, Inc. · Sep 2013
ADVANCE 18LP LOW PROFILE PTA BALLOON DILATATION CATHETER
K130293 · Cook, Inc. · May 2013
ULTRAVERSE RX PTA BALLOON DILATATION CATHETER
K131199 · Bard Peripheral Vascular, Inc. · May 2013